未及時披露重大事件 魯抗醫藥(600789.SH)及相關人員被警示
格隆匯 11 月 24日丨魯抗醫藥(600789.SH)公佈,公司於2020年11月24日收到中國證券監督管理委員會山東監管局(“山東證監局”)於2020年11月23日印發的《關於對山東魯抗醫藥股份有限公司及郭琴、彭欣、田立新採取出具警示函措施的決定》([2020]62號),現將主要內容公告如下:
原因系,2018年1月24日,公司與濟寧市國土資源管理局簽訂了《濟寧市國有建設用地使用權收回合同》,濟寧市國土資源管理局擬收回公司北廠區兩宗國有建設用地使用權作為政府儲備土地,補償費用合計為4.8397億元,佔公司2017年末經審計淨資產24.72%。對於該重大事件,公司未及時予以披露,直至2018年2月26日方才召開董事會進行審議並披露。
公司的上述行為違反了《上市公司信息披露管理辦法》第三十條的規定。郭琴作為公司時任董事長、彭欣作為公司總經理、田立新作為公司董事會祕書,郭琴、彭欣、田立新的行為違反了《上市公司信息披露管理辦法》第三條的規定。按照《上市公司信息披露管理辦法》第五十八條、五十九條的規定,山東證監局決定對公司及郭琴、彭欣、田立新採取出具警示函的監管措施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.